Leukocytosis associated with clozapine in elderly patient

JAVED ATHER SIDDIQUI
2020 Figshare  
Clozapine is the second‑generation antipsychotic which is approved by the US Food and Drug Administrationfor the treatment of refractory schizophrenia. Clozapine is unfortunately associated with number of adverseeffects, one of the chief concerns is agranulocytosis and occasionally leukocytosis, i.e. elevation of whiteblood cell count. In some cases, the leukocytosis may be persistent. We report the case of a 65‑year‑old patientdiagnosed with schizophrenia, who also fulfilled the criteria of
more » ... the criteria of treatment‑resistant schizophrenia, treated withclozapine as patient experienced leukocytosis
doi:10.6084/m9.figshare.11845122 fatcat:aksbulnejrbxbhozhpatsbhdua